Łukasz Starczewski, “Clinical Efficacy, Mechanism of Action, and Adverse Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes – a Systematic Review”, Qual Sport, vol. 54, Apr. 2026.